For the third quarter of the fiscal year ending March 2026, net sales amounted to 28,719 million yen (4.3% decrease year-over-year), operating income was 2,088 million yen (38.7% decrease year-over-year), and quarterly net income attributable to owners of the parent was 1,438 million yen (47.4% decrease year-over-year).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3593","jir_company_name":"Hogi Medical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-29","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/3593-20260129-01.pdf","jir_short_summary":"For the third quarter of the fiscal year ending March 2026, net sales amounted to 28,719 million yen (4.3% decrease year-over-year), operating income was 2,088 million yen (38.7% decrease year-over-year), and quarterly net income attributable to owners of the parent was 1,438 million yen (47.4% decrease year-over-year).","jir_summary":"### Overview of Performance\nIn the third quarter of the fiscal year ending March 2026, net sales were 28,719 million yen (4.3% decrease year-over-year), operating income was 2,088 million yen (38.7% decrease year-over-year), and quarterly net income attributable to owners of the parent was 1,438 million yen (47.4% decrease year-over-year). Pressure on cost reductions at medical institutions and intensified competition with rival products significantly impacted operating and net income. Selling, general and administrative expenses increased due to higher investment-related costs including recruitment, research and development, and digital transformation (DX) expenses. The equity ratio improved to 78.8% compared to the same period last year.\n\n### Outlook and Management Policy\nThe full-year consolidated earnings forecast anticipates net sales of 39,240 million yen (0.3% increase compared to previous fiscal year), operating income of 2,770 million yen (27.3% decrease), and net income attributable to owners of the parent of 2,030 million yen (33.5% increase). We will strengthen value-added proposals focusing on key facilities, emphasize promotion of premium kits and acquisition of new customers. Although manufacturing costs are expected to increase due to rising raw material prices, efforts will be made to reduce costs and improve productivity. We will promote structural reforms based on the medium-term management plan aiming for sustainable mid- to long-term growth.","jir_financial_highlights":"Net Sales: 28,719 million yen (4.3% decrease year-over-year)\nOperating Income: 2,088 million yen (38.7% decrease year-over-year)\nOrdinary Income: 1,873 million yen (42.7% decrease year-over-year)\nQuarterly Net Income Attributable to Owners of Parent: 1,438 million yen (47.4% decrease year-over-year)\nEquity Ratio: 78.8% (2.9 points increase year-over-year)\nNumber of Outstanding Shares (Common Stock): 22,535,463 shares (Same as previous fiscal year-end)\nDividend Forecast (Annual): 47.50 yen (Increased from previous fiscal year (interim dividend increased from 80.00 yen to 47.50 yen))\nFull-year Earnings Guidance for Fiscal Year Ending March 2026 Net Sales: 39,240 million yen (0.3% increase year-over-year)\nFull-year Earnings Guidance for Fiscal Year Ending March 2026 Operating Income: 2,770 million yen (27.3% decrease year-over-year)\nFull-year Earnings Guidance for Fiscal Year Ending March 2026 Net Income Attributable to Owners of Parent: 2,030 million yen (33.5% increase year-over-year)","jir_category":"","jir_hashtags":"#HogiMedical, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net Sales: 28,719 million yen (4.3% decrease year-over-year)\nOperating Income: 2,088 million yen (38.7% decrease year-over-year)\nQuarterly Net Income Attributable to Owners of Parent: 1,438 million yen (47.4% decrease year-over-year)","jir_meta_title":"Hogi Medical Co., Ltd. Q3 Financial Summary for Fiscal Year Ending March 2026: Net Sales 28,719 Million Yen, Operating Income 2,088 Million Yen","jir_meta_description":"Hogi Medical Co., Ltd.'s Q3 financial summary for the fiscal year ending March 2026. Net sales of 28,719 million yen (4.3% decrease year-over-year), operating income of 2,088 million yen (38.7% decrease), net income of 1,438 million yen (47.4% decrease). Full-year earnings guidance also included.","jir_og_title":"Hogi Medical Q3 Fiscal Year Ending March 2026 Financial Results Announcement","jir_og_description":"Net sales of 28,719 million yen, operating income of 2,088 million yen, net income of 1,438 million yen. Reporting on performance trends amid intensified competition.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q3 Fiscal Year Ending March 2025\\\",\\\"Q3 Fiscal Year Ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[30016,28719],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q3 Fiscal Year Ending March 2025\\\",\\\"Q3 Fiscal Year Ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[3406,2088],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_income_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Quarterly Net Income Attributable to Owners of Parent Trend (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q3 Fiscal Year Ending March 2025\\\",\\\"Q3 Fiscal Year Ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Quarterly Net Income\\\",\\\"data\\\":[2736,1438],\\\"borderColor\\\":\\\"#3cba9f\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"equity_ratio_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Equity Ratio Trend (%)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q3 Fiscal Year Ending March 2025\\\",\\\"Q3 Fiscal Year Ending March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Equity Ratio\\\",\\\"data\\\":[75.9,78.8],\\\"backgroundColor\\\":\\\"#e8c3b9\\\"}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true,\\\"max\\\":100}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Kit Products Sales Breakdown (Million Yen)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Total Kit Products\\\",\\\"Premium Kits\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[19325,10228],\\\"backgroundColor\\\":[\\\"#ff6384\\\",\\\"#36a2eb\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true}}\"}]","ir_related_company":9238,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-21786","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n